Lena Biosciences
Atlanta
About Lena Biosciences
Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapies, biomedical research and drug testing. Its new PerfusionPal product is a high-throughput organ-on-a-chip insert system that yields up to 5 times greater drug metabolism. It fits into existing workflows and enables customers to emulate multiple organs, deliver and test drugs in a standard format for ADME Tox screening, cancer research, and precision therapies. Owing to concentrated secretome and metabolome, PerfusionPal is ideally suited for testing slow-to-metabolize drugs and biologics (monoclonal antibodies and antibody-drug conjugates).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Funding stage: Seed
- Last round: Grant (Aug 2020)
- Website: lenabio.com
- Phone: (404) 375-2030
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/lena-biosciences-7008 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.